Synergistic Hydrocortisone Sodium Phosphate Combinations for Enhanced Therapeutic Outcomes

This inventive concept integrates hydrocortisone sodium phosphate with cutting-edge technologies like AI, IoT, blockchain, and novel materials to create powerful systems for personalized medicine, co-administration, wearable devices, implants, and predictive dosing regimens, enhancing therapeutic outcomes for allergic reactions and inflammatory skin conditions.

The original patent disclosed an aqueous pharmaceutical formulation of hydrocortisone sodium phosphate and monothioglycerol. However, it lacked the integration with distinct technologies to create more powerful systems. This inventive concept addresses the limitation by combining the formulation with AI, IoT, blockchain, and novel materials to provide more effective and personalized treatments.

The synergistic combinations comprise a hydrocortisone sodium phosphate aqueous pharmaceutical formulation integrated with AI-driven dosing algorithms for customized treatment, blockchain-secured supply chain management systems for ensuring authenticity and trackability, IoT-enabled sensors for real-time monitoring of skin conditions, micro-needling systems for enhanced drug delivery, biocompatible polymer matrices for implantable devices, and machine learning algorithms for predicting optimal dosing regimens. These combinations enable personalized medicine, co-administration, wearable devices, implants, and predictive dosing regimens.

The novelty of this inventive concept lies in the integration of the hydrocortisone sodium phosphate formulation with distinct technologies, creating powerful systems that were not obvious from the original patent. The inventive step is the recognition of the potential of these synergistic combinations to enhance therapeutic outcomes.

Alternative embodiments may include varying the AI-driven dosing algorithms, blockchain protocols, IoT sensor configurations, and novel material compositions to accommodate different patient populations, disease states, or treatment regimens. Variations may also involve integrating additional technologies, such as nanotechnology or gene editing, to further enhance the therapeutic outcomes.

The synergistic combinations have significant commercial potential in the pharmaceutical, biotechnology, and healthcare industries, particularly in the areas of personalized medicine, dermatology, and immunology. The market demand for more effective and personalized treatments for allergic reactions and inflammatory skin conditions is substantial, and these combinations are poised to capture a significant share of this market.